BioSpace News Archive

The first two webinars in AMPLEXOR Life Sciences’ 2019 webinar program have been announced, focusing on “Regulatory Information Management: Delivering Better Efficiencies Across Operations” and “Ensuring Compliance for Pharma Companies Through Local Label Deviations.”

Boehringer Ingelheim and GNA Biosolutions announce that they have entered into a research collaboration focused on the development of a rapid African swine fever (ASF) diagnostic test.

Montana’s largest provider of workers’ compensation insurance, Montana State Fund, is partnering with Rising Medical Solutions, a national managed care company, to administer its medical bill repricing and provider payment program.

Leading Health Group Becomes Member of National Behavioral Healthcare Advocacy Organization

Winners receive up to $50,000, plus an opportunity to participate in a one-of-a-kind pediatric accelerator program

Innovus Pharmaceuticals, Inc. announced that its subsidiary, Novalere, Inc., has launched its product line into the hemp-derived, cannabinoid oil-based products with the introduction of MZS Sleeping Aid™, a dietary supplement in tincture form delivering a 3 mg dose of melatonin per serving that incorporates either a 100 or 250 mg of hemp-derived CBD oil.

Company’s multiplexed Logix Smart™ ZDC Test to be available for purchase with CE mark in March 2019

Lannett Company, Inc. announced its participation at two upcoming investor conferences.

AstraZeneca and Merck’s LYNPARZA Is the First PARP Inhibitor to Demonstrate Benefit in gBRCAm Metastatic Pancreatic Cancer in a Phase 3 Trial

AstraZeneca and Merck’s LYNPARZA is the first PARP inhibitor to demonstrate benefit in gBRCAm metastatic pancreatic cancer in a Phase III Trial